Faqing Ye

1.4k total citations
48 papers, 1.1k citations indexed

About

Faqing Ye is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Faqing Ye has authored 48 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 17 papers in Organic Chemistry and 7 papers in Pharmacology. Recurrent topics in Faqing Ye's work include Synthesis and biological activity (11 papers), Fibroblast Growth Factor Research (7 papers) and Analytical Methods in Pharmaceuticals (5 papers). Faqing Ye is often cited by papers focused on Synthesis and biological activity (11 papers), Fibroblast Growth Factor Research (7 papers) and Analytical Methods in Pharmaceuticals (5 papers). Faqing Ye collaborates with scholars based in China, Germany and United States. Faqing Ye's co-authors include Xiaokun Li, Shulin Yang, Guang Liang, Yuepiao Cai, Yueru Li, Yong Pan, Jianzhang Wu, Yali Zhang, Yunjie Zhao and Jianling Li and has published in prestigious journals such as PLoS ONE, Journal of Medicinal Chemistry and Molecules.

In The Last Decade

Faqing Ye

47 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Faqing Ye China 19 460 404 180 175 94 48 1.1k
Norbert Handler Austria 14 430 0.9× 243 0.6× 109 0.6× 69 0.4× 88 0.9× 34 1.0k
Darrick S. H. L. Kim United States 18 787 1.7× 265 0.7× 259 1.4× 283 1.6× 70 0.7× 27 1.6k
Yusuf Al‐Hiari Jordan 17 325 0.7× 385 1.0× 153 0.8× 47 0.3× 65 0.7× 98 962
Yuepiao Cai China 25 827 1.8× 351 0.9× 174 1.0× 249 1.4× 139 1.5× 66 1.7k
Dharmendra Kumar Maurya India 22 617 1.3× 145 0.4× 134 0.7× 41 0.2× 190 2.0× 56 1.7k
Peihong Qiu China 16 330 0.7× 329 0.8× 66 0.4× 82 0.5× 69 0.7× 34 813
Bathini Nagendra Babu India 28 730 1.6× 1.5k 3.6× 150 0.8× 55 0.3× 109 1.2× 93 2.1k
Falak Thakral India 6 681 1.5× 114 0.3× 103 0.6× 60 0.3× 170 1.8× 8 1.4k
Nilanjan Ghosh India 15 336 0.7× 151 0.4× 187 1.0× 31 0.2× 114 1.2× 34 1.0k
Ketan C. Ruparelia United Kingdom 20 697 1.5× 221 0.5× 169 0.9× 31 0.2× 265 2.8× 41 1.7k

Countries citing papers authored by Faqing Ye

Since Specialization
Citations

This map shows the geographic impact of Faqing Ye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Faqing Ye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Faqing Ye more than expected).

Fields of papers citing papers by Faqing Ye

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Faqing Ye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Faqing Ye. The network helps show where Faqing Ye may publish in the future.

Co-authorship network of co-authors of Faqing Ye

This figure shows the co-authorship network connecting the top 25 collaborators of Faqing Ye. A scholar is included among the top collaborators of Faqing Ye based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Faqing Ye. Faqing Ye is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Xuebao, Ying Lu, Jinxia Zhang, et al.. (2024). Discovery of a prominent dual-target DDR1/EGFR inhibitor aimed DDR1/EGFR-positive NSCLC. Bioorganic Chemistry. 149. 107500–107500. 6 indexed citations
2.
Xu, Xuemei, Siyu Chen, Jinxia Zhang, et al.. (2024). Synthesis and biological evaluation of novel benzothiazole derivatives as potential anticancer and antiinflammatory agents. Frontiers in Chemistry. 12. 1384301–1384301. 16 indexed citations
3.
Zhang, Yuan, Zihan Wang, Wan‐Ping Hu, et al.. (2024). Inhibition of DDR1 promotes ferroptosis and overcomes gefitinib resistance in non-small cell lung cancer. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1870(7). 167447–167447. 8 indexed citations
4.
Zhao, Yunjie, et al.. (2024). Synthesis, characterization, and anticancer activity of syringaldehyde-derived chalcones against female cancers. Medicinal Chemistry Research. 33(3). 532–547. 1 indexed citations
5.
6.
Chen, Xiaojing, Lu Liu, Yue Ma, et al.. (2021). Synthesis and biological evaluation of novel N-substituted benzamides as anti-migration agents for treatment of osteosarcoma. European Journal of Medicinal Chemistry. 214. 113203–113203. 4 indexed citations
7.
Wang, Xuebao, Kaiqi Wu, Xiaojiao Yang, et al.. (2021). Discovery of N-substituted sulfamoylbenzamide derivatives as novel inhibitors of STAT3 signaling pathway based on Niclosamide. European Journal of Medicinal Chemistry. 218. 113362–113362. 14 indexed citations
8.
Xie, Zixin, Kaiqi Wu, Yuexuan Wang, et al.. (2019). Discovery of 4,6-pyrimidinediamine derivatives as novel dual EGFR/FGFR inhibitors aimed EGFR/FGFR1-positive NSCLC. European Journal of Medicinal Chemistry. 187. 111943–111943. 23 indexed citations
9.
Zhang, Yuan, Lu Luo, Yong Xu, et al.. (2018). Design, synthesis and pharmacological evaluation of N4,N6-disubstituted pyrimidine-4,6-diamine derivatives as potent EGFR inhibitors in non-small cell lung cancer. European Journal of Medicinal Chemistry. 157. 1300–1325. 18 indexed citations
10.
Wang, Xuebao, Chao Han, Kaiqi Wu, et al.. (2018). Design, synthesis and ability of non-gold complexed substituted purine derivatives to inhibit LPS-induced inflammatory response. European Journal of Medicinal Chemistry. 149. 10–21. 10 indexed citations
11.
Ye, Faqing, Yuewu Wang, Yu Wang, et al.. (2015). Synthesis and evaluation of biological and antitumor activities of 5,7-dimethyl- oxazolo[5,4-d]pyrimidine-4,6(5H,7H)-dione derivatives as novel inhibitors of FGFR1. Journal of Enzyme Inhibition and Medicinal Chemistry. 30(6). 961–966. 12 indexed citations
12.
13.
Guo, Ping, et al.. (2013). Synthesis, anti-tumor activity, and structure–activity relationships of curcumol derivatives. Journal of Asian Natural Products Research. 16(1). 53–58. 20 indexed citations
14.
Gao, Hongchang, Li Lin, Yun Xiang, et al.. (2012). Metabolic Changes Detected by Ex Vivo High Resolution 1H NMR Spectroscopy in the Striatum of 6-OHDA-Induced Parkinson’s Rat. Molecular Neurobiology. 47(1). 123–130. 42 indexed citations
15.
Zhang, Haiyan, et al.. (2011). 1H NMR-based metabonomics study on serum of renal interstitial fibrosis rats induced by unilateral ureteral obstruction. Molecular BioSystems. 8(2). 595–601. 24 indexed citations
16.
Hu, Guoxin, et al.. (2011). Design and synthesis of 8-substituted benzamido-phenylxanthine derivatives as MAO-B inhibitors. Bioorganic & Medicinal Chemistry Letters. 22(4). 1739–1742. 27 indexed citations
17.
Wang, Yi, Yong Pan, Jianling Li, et al.. (2011). A Novel Compound C12 Inhibits Inflammatory Cytokine Production and Protects from Inflammatory Injury In Vivo. PLoS ONE. 6(9). e24377–e24377. 26 indexed citations
18.
Wang, Xianqin, Jiayin Zhu, Ren-ai Xu, et al.. (2010). Determination of piracetam in rat plasma by LC–MS/MS and its application to pharmacokinetics. Biomedical Chromatography. 24(10). 1108–1112. 14 indexed citations
19.
Liang, Guang, Shulin Yang, Lijuan Jiang, et al.. (2008). Synthesis and Anti-bacterial Properties of Mono-carbonyl Analogues of Curcumin. Chemical and Pharmaceutical Bulletin. 56(2). 162–167. 120 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Norbert Handler Breakdown of academic impact, for papers by Darrick S. H. L. Kim Breakdown of academic impact, for papers by Yusuf Al‐Hiari Breakdown of academic impact, for papers by Yuepiao Cai Breakdown of academic impact, for papers by Dharmendra Kumar Maurya Breakdown of academic impact, for papers by Peihong Qiu Breakdown of academic impact, for papers by Bathini Nagendra Babu Breakdown of academic impact, for papers by Falak Thakral Breakdown of academic impact, for papers by Nilanjan Ghosh Breakdown of academic impact, for papers by Ketan C. Ruparelia
Rankless by CCL
2026